CVS names Joyner as CEO under investor pressure, withdraws profit forecast
CVS Health on Friday replaced CEO Karen Lynch with David Joyner, a CVS veteran who retired before returning to the company last year, after investors including activist Glenview Capital pressured the company to improve its stagnant share price.
America’s largest drug store chain named a new chief executive officer on Friday, with longtime CVS Health executive David ...
CVS Health stock sold for $72.08 a share when Karen Lynch became president and CEO in 2021. It closed at $60.35 on Friday.
Shares of the health care conglomerate dropped after the sudden departure of Karen Lynch and a downbeat update on the state ...
CVS Health said Friday that as of Thursday David Joyner became its new CEO, replacing Karen Lynch. In an agreement with the ...
CVS Health on Friday replaced CEO Karen Lynch with David Joyner, a CVS veteran who retired before returning to the company ...
MT Newswires on MSN9h
CVS Names New CEO, Offers Downbeat Third-Quarter Earnings OutlookCVS Health (CVS) said Friday that it named David Joyner as its new chief executive while the healthcare giant issued a preliminary third-quarter earnings outlook that came in below Wall Street's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback